2025 · 2nd Quarter (Apr 1 - June 30)

MERCK & CO INC

Filed by WILLIAMS AND JENSEN, PLLC.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 21, 2025
Income: $50,000.00
Expenses: Not reported
Registrant: WILLIAMS AND JENSEN, PLLC
Client: MERCK & CO INC
Filing UUID: 587730f3-aad6-4329-b5da-f6950e6b12d8
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Drug pricing proposals. Pharmacy Benefit Manager reform proposals. 340B. Vaccine access issues.

TAX · Taxation/Internal Revenue Code

Tax policy impacting health care and pharmaceutical industry. OBBB.

MMM · Medicare/Medicaid

Drug pricing proposals. Pharmacy Benefit Manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. Implementation of IRA.

Literal federal measure citations: H.R. 1

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.